English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Asthma and Allergy Foundation of America
+
Pharmaceuticals
Patient Daily
| Jun 30, 2026
AAFA advises asthma patients to take precautions during summer hazards
+
Pharmaceuticals
Patient Daily
| Jun 18, 2026
Patient groups announce first-ever drug development meeting for chronic cough in October 2026
+
Pharmaceuticals
Patient Daily
| Jun 11, 2026
Asthma and Allergy Friendly Certification Program partners with Chicago Asthma Consortium for education forum
+
Pharmaceuticals
Patient Daily
| May 5, 2026
AAFA and AAAAI urge Congress to protect programs for asthma and allergy patients
+
Pharmaceuticals
Patient Daily
| Apr 30, 2026
AAFA highlights community support during National Asthma and Allergy Awareness Month
+
Pharmaceuticals
Patient Daily
| Apr 23, 2026
AAFA announces new resources for nasal polyps on Global CRSwNP Awareness Day
+
Pharmaceuticals
Patient Daily
| Apr 16, 2026
Mohawk SmartStrand carpet styles receive asthma and allergy friendly certification
+
Pharmaceuticals
Patient Daily
| Apr 9, 2026
AAFA report shows longer, more intense pollen seasons challenge allergy management in 2026
Trending
+
Pharmaceuticals
Patient Daily
| Aug 6, 2026
FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+
Regulatory
M. Y. Bailey
| Aug 7, 2026
PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports
| Aug 10, 2026
SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+
Pharmaceuticals
Patient Daily
| Aug 7, 2026
Researchers develop computer model linking brain chemistry to neural activity patterns
